title: Musculoskeletal pain in patients with chronic myeloid leukemia after discontinuation of imatinib: a tyrosine kinase inhibitor withdrawal syndrome?
authors: Skåne University Hospital, Lund, Sweden Johan.Richter@med.lu.se.
authors: Johan
authors: J
authors: Richter
authors: University Hospital, Uppsala, Sweden.
authors: Stina
authors: S
authors: Söderlund
authors: Skåne University Hospital, Lund, Sweden.
authors: Anna
authors: A
authors: Lübking
authors: University Hospital, Linköping, Sweden.
authors: Arta
authors: A
authors: Dreimane
authors: University Hospital, Linköping, Sweden.
authors: Kourosh
authors: K
authors: Lotfi
authors: University Hospital, Umeå, Sweden.
authors: Berit
authors: B
authors: Markevärn
authors: Umeå University, Umeå, Sweden.
authors: Anders
authors: A
authors: Själander
authors: Universitätsmedizin Mannheim, Mannheim, Germany.
authors: Susanne
authors: S
authors: Saussele
authors: University Hospital, Uppsala, Sweden.
authors: Ulla
authors: U
authors: Olsson-Strömberg
authors: Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden.
authors: Leif
authors: L
authors: Stenke
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001549:Benzamides / Q000008:administration & dosage*; D005260:Female; D016044:Fusion Proteins, bcr-abl / Q000037:antagonists & inhibitors*; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy*; D008297:Male; D010879:Piperazines / Q000008:administration & dosage*; D047428:Protein Kinase Inhibitors / Q000008:administration & dosage*; D011743:Pyrimidines / Q000008:administration & dosage*
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D016044:Fusion Proteins, bcr-abl